Cargando…
Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis
BACKGROUND: Immunotherapy for lung cancer has been a hot research area for years. This bibliometric analysis aims to present the research trends on lung cancer immunotherapy. METHOD: On 1 July, 2022, the authors identified 2,941 papers on lung cancer immunotherapy by the Web of Science and extracte...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751816/ https://www.ncbi.nlm.nih.gov/pubmed/36532038 http://dx.doi.org/10.3389/fimmu.2022.1032747 |
_version_ | 1784850565731188736 |
---|---|
author | Liu, Yanhao Cheng, Xu Han, Xiaona Cheng, Xi Jiang, Shu Lin, Yaru Zhang, Zhen Lu, Linlin Qu, Baozhen Chen, Yuxian Zhang, Xiaotao |
author_facet | Liu, Yanhao Cheng, Xu Han, Xiaona Cheng, Xi Jiang, Shu Lin, Yaru Zhang, Zhen Lu, Linlin Qu, Baozhen Chen, Yuxian Zhang, Xiaotao |
author_sort | Liu, Yanhao |
collection | PubMed |
description | BACKGROUND: Immunotherapy for lung cancer has been a hot research area for years. This bibliometric analysis aims to present the research trends on lung cancer immunotherapy. METHOD: On 1 July, 2022, the authors identified 2,941 papers on lung cancer immunotherapy by the Web of Science and extracted their general information and the total number of citations. A bibliometric analysis was carried out to present the research landscape, demonstrate the research trends, and determine the most cited papers (top papers) as well as major journals on lung cancer immunotherapy. After that, recent research hotspots were analyzed based on the latest publications in major journals. RESULTS: These 2,941 papers were cited a total of 122,467 times. “Nivolumab vs. docetaxel in advanced non–squamous non–small–cell lung cancer” published in 2015 by Borghaei H et al. was the most cited paper (5,854 citations). Among the journals, New England Journal of Medicine was most influential. Corresponding authors represented China took part in most articles (904) and papers with corresponding authors from the USA were most cited (139.46 citations per paper). Since 2015, anti–PD–(L)1 has become the hottest research area. CONCLUSIONS: This bibliometric analysis comprehensively and quantitatively presents the research trends and hotspots based on thousands of publications, and further suggests future research directions. Moreover, the results can benefit researchers to select journals and find potential collaborators. This study can help researchers get a comprehensive impression of the research landscape, historical development, and recent hotspots in lung cancer immunotherapy and provide inspiration for further research. |
format | Online Article Text |
id | pubmed-9751816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97518162022-12-16 Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis Liu, Yanhao Cheng, Xu Han, Xiaona Cheng, Xi Jiang, Shu Lin, Yaru Zhang, Zhen Lu, Linlin Qu, Baozhen Chen, Yuxian Zhang, Xiaotao Front Immunol Immunology BACKGROUND: Immunotherapy for lung cancer has been a hot research area for years. This bibliometric analysis aims to present the research trends on lung cancer immunotherapy. METHOD: On 1 July, 2022, the authors identified 2,941 papers on lung cancer immunotherapy by the Web of Science and extracted their general information and the total number of citations. A bibliometric analysis was carried out to present the research landscape, demonstrate the research trends, and determine the most cited papers (top papers) as well as major journals on lung cancer immunotherapy. After that, recent research hotspots were analyzed based on the latest publications in major journals. RESULTS: These 2,941 papers were cited a total of 122,467 times. “Nivolumab vs. docetaxel in advanced non–squamous non–small–cell lung cancer” published in 2015 by Borghaei H et al. was the most cited paper (5,854 citations). Among the journals, New England Journal of Medicine was most influential. Corresponding authors represented China took part in most articles (904) and papers with corresponding authors from the USA were most cited (139.46 citations per paper). Since 2015, anti–PD–(L)1 has become the hottest research area. CONCLUSIONS: This bibliometric analysis comprehensively and quantitatively presents the research trends and hotspots based on thousands of publications, and further suggests future research directions. Moreover, the results can benefit researchers to select journals and find potential collaborators. This study can help researchers get a comprehensive impression of the research landscape, historical development, and recent hotspots in lung cancer immunotherapy and provide inspiration for further research. Frontiers Media S.A. 2022-12-01 /pmc/articles/PMC9751816/ /pubmed/36532038 http://dx.doi.org/10.3389/fimmu.2022.1032747 Text en Copyright © 2022 Liu, Cheng, Han, Cheng, Jiang, Lin, Zhang, Lu, Qu, Chen and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Liu, Yanhao Cheng, Xu Han, Xiaona Cheng, Xi Jiang, Shu Lin, Yaru Zhang, Zhen Lu, Linlin Qu, Baozhen Chen, Yuxian Zhang, Xiaotao Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis |
title | Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis |
title_full | Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis |
title_fullStr | Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis |
title_full_unstemmed | Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis |
title_short | Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis |
title_sort | global research landscape and trends of lung cancer immunotherapy: a bibliometric analysis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751816/ https://www.ncbi.nlm.nih.gov/pubmed/36532038 http://dx.doi.org/10.3389/fimmu.2022.1032747 |
work_keys_str_mv | AT liuyanhao globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT chengxu globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT hanxiaona globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT chengxi globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT jiangshu globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT linyaru globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT zhangzhen globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT lulinlin globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT qubaozhen globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT chenyuxian globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis AT zhangxiaotao globalresearchlandscapeandtrendsoflungcancerimmunotherapyabibliometricanalysis |